News

October 15, 2019

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

October 15, 2019

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering

September 25, 2019

Rhythm Pharmaceuticals Provides Update on Research and Development Programs

September 9, 2019

Rhythm Pharmaceuticals to Provide an Update on Genetic Sequencing Efforts and Expansion of Phase 2 Basket Study with Four Additional Rare MC4R Pathway-driven Disorders

September 3, 2019

Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September

August 7, 2019

Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities

July 29, 2019

Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results

July 29, 2019

Rhythm Pharmaceuticals Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for Setmelanotide for the Treatment of Bardet-Biedl Syndrome

July 24, 2019

Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors

July 17, 2019

Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity

June 19, 2019

Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors

May 30, 2019

Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference

May 7, 2019

Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference

May 3, 2019

Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results

April 2, 2019

Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference

March 28, 2019

Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development

March 8, 2019

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

March 4, 2019

Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference

January 4, 2019

Rhythm Pharmaceuticals to Outline Expected 2019 Milestones and Review Updated Clinical Data in Bardet-Biedl Syndrome at 37th Annual J.P. Morgan Healthcare Conference